TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/21/24 16:07 | 5/20/24 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | S.d | -500 | 49.99 | 0 | -10 | -15 | 58 | D | ||||||||||||||
11/22/23 16:05 | 11/20/23 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | S.d | -182 | 36.40 | 0 | -5 | -9 | 53 | D | ||||||||||||||
3/3/22 16:06 | 3/1/22 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | S.d | -693 | 41.43 | 0 | -17 | -25 | 49 | D | ||||||||||||||
12/22/21 18:54 | 12/20/21 | VCEL | Vericel Corp | MI | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | S.dm | -637 | 40.11 | 0 | -16 | -27 | 44 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |